Table 2. Comparing percent positivity of immunohistochemistry and flow cytometry in chronic lymphocytic leukemia and non Hodgkin lymphoma groups.
Marker | IHC (No of positive cases) | Flow cytometry (% positivity) | P | Sig. | |
---|---|---|---|---|---|
CD20 | CLL | 9 | 76.9 | 0.814 | NS |
NHL | 21 | 49.1 | 0.01 | S | |
CD5 | CLL | 11 | 53.1 | 0.237 | NS |
NHL | 11 | 6.3 | 0.02 | S | |
CD23 | CLL | 5 | 67.2 | 0.118 | NS |
NHL | 3 | 6.1 | 0.049 | S | |
Kappa | CLL | 2 | 35 | 0.231 | NS |
NHL | 5 | 16.8 | 0.025 | S | |
Lambda | CLL | 1 | 2.4 | 0.251 | NS |
NHL | 7 | 5.9 | 0.006 | HS |
ICH, immunohistochemistry; CCL, chronic lymphocytic leukemia; NHL, non Hodgkin lymphoma; NS, Non-significant; S, Significant; HS, Highly-significant.